Literature DB >> 35945361

An integrative-omics analysis of an industrial clavulanic acid-overproducing Streptomyces clavuligerus.

Aslıhan Kurt-Kızıldoğan1, Gözde Çelik2, Eser Ünsaldı2,3, Servet Özcan4, Şerife Ayaz-Güner5,6, Gülay Özcengiz7.   

Abstract

Clavulanic acid (CA) is a clinically important secondary metabolite used to treat infectious diseases. We aimed to decipher complex regulatory mechanisms acting in CA biosynthesis by analyzing transcriptome- and proteome-wide alterations in an industrial CA overproducer Streptomyces clavuligerus strain, namely DEPA and its wild-type counterpart NRRL3585. A total of 924 differentially expressed genes (DEGs) and 271 differentially produced proteins (DPPs) were obtained by RNA-seq and nanoLC-MS/MS analyses, respectively. In particular, CA biosynthetic genes, namely, car (cad), cas2, oat2, pah, bls, ceas2, orf12, and claR, a cluster situated regulatory (CSR) gene, were significantly upregulated as shown by RNA-seq. Enzymes of clavam biosynthesis were downregulated considerably in the DEPA strain, while the genes involved in the arginine biosynthesis, one of the precursors of CA pathway, were overexpressed. However, the biosynthesis of the other CA precursor, glyceraldehyde-3-phosphate (G3P), was not affected. CA overproduction in the DEPA strain was correlated with BldD, BldG, BldM, and BldN (AdsA) overrepresentation. In addition, TetR, WhiB, and Xre family transcriptional regulators were shown to be significantly overrepresented. Several uncharacterized/unknown proteins differentially expressed in the DEPA strain await further studies for functional characterization. Correlation analysis indicated an acceptable degree of consistency between the transcriptome and proteome data. The study represents the first integrative-omics analysis in a CA overproducer S. clavuligerus strain, providing insights into the critical control points and potential rational engineering targets for a purposeful increase of CA yields in strain improvement. KEY POINTS: ∙ Transcriptome and proteome-wide alterations in industrial CA overproducer strain DEPA ∙ An acceptable degree of consistency between the transcriptome and proteome data ∙ New targets to be exploited for rational engineering.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Clavulanic acid overproduction; RNA-seq; Streptomyces clavuligerus DEPA; nanoLC-MS/MS

Mesh:

Substances:

Year:  2022        PMID: 35945361     DOI: 10.1007/s00253-022-12098-4

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   5.560


  43 in total

1.  Biostatistics 104: correlational analysis.

Authors:  Y H Chan
Journal:  Singapore Med J       Date:  2003-12       Impact factor: 1.858

2.  Expression of ccaR, encoding the positive activator of cephamycin C and clavulanic acid production in Streptomyces clavuligerus, is dependent on bldG.

Authors:  Dawn R D Bignell; Kapil Tahlan; Kimberley R Colvin; Susan E Jensen; Brenda K Leskiw
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  Mutants of Streptomyces clavuligerus with disruptions in different genes for clavulanic acid biosynthesis produce large amounts of holomycin: possible cross-regulation of two unrelated secondary metabolic pathways.

Authors:  Alvaro de la Fuente; Luis M Lorenzana; Juan F Martín; Paloma Liras
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

4.  Two proteins with ornithine acetyltransferase activity show different functions in Streptomyces clavuligerus: Oat2 modulates clavulanic acid biosynthesis in response to arginine.

Authors:  A de la Fuente; J F Martín; A Rodríguez-García; P Liras
Journal:  J Bacteriol       Date:  2004-10       Impact factor: 3.490

5.  Nitrogen nutrition and regulation of cephalosporin production in Streptomyces clavuligerus.

Authors:  Y Aharonowitz; A L Demain
Journal:  Can J Microbiol       Date:  1979-01       Impact factor: 2.419

Review 6.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

7.  Transcriptomic analysis of Streptomyces clavuligerus ΔccaR::tsr: effects of the cephamycin C-clavulanic acid cluster regulator CcaR on global regulation.

Authors:  R Alvarez-Álvarez; A Rodríguez-García; I Santamarta; R Pérez-Redondo; A Prieto-Domínguez; Y Martínez-Burgo; P Liras
Journal:  Microb Biotechnol       Date:  2014-01-22       Impact factor: 5.813

8.  Multi-layered inhibition of Streptomyces development: BldO is a dedicated repressor of whiB.

Authors:  Matthew J Bush; Govind Chandra; Kim C Findlay; Mark J Buttner
Journal:  Mol Microbiol       Date:  2017-03-27       Impact factor: 3.501

Review 9.  c-di-GMP signalling and the regulation of developmental transitions in streptomycetes.

Authors:  Matthew J Bush; Natalia Tschowri; Susan Schlimpert; Klas Flärdh; Mark J Buttner
Journal:  Nat Rev Microbiol       Date:  2015-10-26       Impact factor: 60.633

10.  Comparative Genomics and Metabolomics Analyses of Clavulanic Acid-Producing Streptomyces Species Provides Insight Into Specialized Metabolism.

Authors:  Nader F AbuSara; Brandon M Piercey; Marcus A Moore; Arshad Ali Shaikh; Louis-Félix Nothias; Santosh K Srivastava; Pablo Cruz-Morales; Pieter C Dorrestein; Francisco Barona-Gómez; Kapil Tahlan
Journal:  Front Microbiol       Date:  2019-11-08       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.